Century Therapeutics Inc (IPSC)
1.46
+0.02
(+1.39%)
USD |
NASDAQ |
Sep 06, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
Century Therapeutics Research and Development Expense (Annual): 92.71M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 92.71M |
| December 31, 2022 | 97.17M |
| December 31, 2021 | 75.65M |
| Date | Value |
|---|---|
| December 31, 2020 | 39.68M |
| December 31, 2019 | 14.27M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
14.27M
Minimum
2019
97.17M
Maximum
2022
63.90M
Average
75.65M
Median
2021
Research and Development Expense (Annual) Benchmarks
| CEL-SCI Corp | 22.47M |
| AIM ImmunoTech Inc | 10.94M |
| IGC Pharma Inc | 3.773M |
| NovaBay Pharmaceuticals Inc | 0.068M |
| Protalix BioTherapeutics Inc | 17.09M |